Why the study?
What are the aetiology and survival outcomes of patients presenting with malignant hypertension?
What are the aetiology and survival outcomes of patients presenting with malignant hypertension?
In patients with malignant hypertension, secondary causes are more common (80%) than primary, and 5-year survival is approximately 75%, with initial serum creatinine serving as a prognostic indicator.
Answers are grounded in this paper and cite their sources.
Supports secondary cause evaluation in malignant hypertension; leaves open prospective validation of survival predictors.
To evaluate the current pattern of aetiology and outcome in malignant hypertension, we reviewed all medical records of patients presenting between 1979 and 1985 who fulfilled WHO criteria for malignant hypertension. There were 83 patients, 43 males (52%) and 40 females (48%). Primary malignant hypertension was diagnosed in 17 cases (20%) and secondary lesions in 66 cases (80%). Overall one year survival was 94%, and 5 year survival 75%, which is similar to recent reports. Initial serum creatinine was a prognostic indicator.
No takes yet. Share an insight, caveat, or question.
Yu et al. (1986) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: